×
For best experience we recommend to activate Javascript in your browser.
Recombinant B7-H3 (Enoblituzumab Biosimilar) antibody (Alexa Fluor 405)
This Humanized Monoclonal antibody specifically detects B7-H3 (Enoblituzumab Biosimilar) in ELISA, FACS and CyTox. It exhibits reactivity toward Human.
Quick Overview for Recombinant B7-H3 (Enoblituzumab Biosimilar) antibody (Alexa Fluor 405) (ABIN7766370)
Target
B7-H3 (Enoblituzumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
All hosts for B7-H3 (Enoblituzumab Biosimilar) antibodies
Humanized
Clonality
All clonalities for B7-H3 (Enoblituzumab Biosimilar) antibodies
Monoclonal
Conjugate
All conjugates for B7-H3 (Enoblituzumab Biosimilar) antibodies
This B7-H3 (Enoblituzumab Biosimilar) antibody is conjugated to Alexa Fluor 405
Application
All applications for B7-H3 (Enoblituzumab Biosimilar) antibodies
ELISA, Flow Cytometry (FACS), Cytotoxicity Test (CyTox)
Product Details anti-B7-H3 (Enoblituzumab Biosimilar) Antibody (Alexa Fluor 405)
(hide)
Purpose
Conjugated Anti-B7-H3 (enoblituzumab biosimilar) mAb
Purification
Purified from cell culture supernatant by affinity chromatography
Alternatives
(show)
Application Details
(hide)
Application Notes
most applications: 1: 50 - 1: 250
Restrictions
For Research Use only
Handling
(hide)
Buffer
Liquid in PBS, 0.5 % BSA, 40 % Glycerol, 0.02 % Sodium Azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handling Advice
Protect from light!
Storage
4 °C
Storage Comment
Store at 4°C in dark for 6 months
Target Details for B7-H3 (Enoblituzumab Biosimilar)
(hide)
Target
B7-H3 (Enoblituzumab Biosimilar)
Alternative Name
enoblituzumab biosimilar
Target Type
Biosimilar
Background
B7-H3, CD276, B7 homolog 3
Recently viewed
(hide)
Chat with us , powered by LiveChat